In a healthy eye, a clear fluid called aqueous humor is continuously produced and drained through specialized structures within the eye. In dogs with POAG-4, genetic abnormalities can interfere with this drainage process. Unlike some other forms of glaucoma that develop suddenly, Primary Open Angle Glaucoma often progresses slowly over time. This gradual onset means that early signs may be subtle and difficult for owners to detect until significant damage has already occurred.
Dogs affected by POAG-4 may initially show mild symptoms such as slight eye discomfort, increased tearing, sensitivity to light, or subtle vision changes. As the disease progresses, signs can become more noticeable and may include enlarged eyes, redness, cloudiness of the cornea, reduced vision, and behavioral changes associated with visual impairment. In advanced cases, irreversible blindness may occur due to damage to the optic nerve. Early detection is therefore critical for preserving vision and improving long-term outcomes.
The POAG-4 DNA Health Test is designed to identify the specific genetic mutation associated with this inherited form of glaucoma. Testing is typically performed using a simple cheek swab or blood sample. The collected sample is analyzed in a specialized laboratory to determine whether the dog carries the mutation linked to POAG-4. Since DNA remains constant throughout life, testing can be performed at any age, including in young puppies before clinical signs appear.
Test results are generally reported in one of three categories:
- Clear (Normal): The dog does not possess the POAG-4 mutation and cannot pass it on to offspring.
- Carrier: The dog carries one copy of the mutation and may not develop the disease but can transmit the mutation to future generations.
- Affected/At Risk: The dog carries two copies of the mutation and has a significantly increased risk of developing Primary Open Angle Glaucoma during its lifetime.
Genetic screening for POAG-4 offers significant benefits to breeders, veterinarians, and dog owners. Breeders can use test results to make informed mating decisions that reduce the likelihood of producing affected puppies while preserving valuable genetic diversity within the breed. Avoiding the breeding of two carrier dogs is an effective strategy for lowering disease prevalence over time.
For dog owners, knowing a pet’s genetic status allows for proactive eye health management. Dogs identified as at risk can undergo regular ophthalmic examinations and intraocular pressure monitoring, helping veterinarians detect changes early and initiate appropriate treatment strategies when necessary. While genetic testing cannot prevent the disease, it provides essential information that supports early intervention and informed healthcare decisions.
The Primary Open Angle Glaucoma (POAG-4) Health Test is a valuable genetic screening tool that promotes responsible breeding, supports canine eye health, and helps reduce the impact of this inherited vision-threatening condition in future generations of dogs.
